Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With annotations already declaring readOnlyHint=false and openWorldHint=true, the description adds real behavioral facts beyond them: a waiting application's link goes out immediately (link: sent), resend_link re-sends it, only the clinician may sign unless i_am_this_clinician=true, and changing contact terminates any signing in progress. That last point is a meaningful side effect disclosed nowhere in the annotations. It stops short of describing failure modes or the full response shape.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The single paragraph is dense and mostly earns its words, but the opening 'Application bundle: ... with the account ID and the access token: npi' is garbled and reads like a mangled parameter list rather than a front-loaded purpose statement. The important side-effect warning ('A changed contact ends any signing in progress') is buried at the end.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For an 8-parameter mutation with full schema coverage and annotations but no output schema, the description covers purpose, the immediate link send, resend behavior, authorization gating, and a destructive side effect. What remains missing is error behavior and whether the contact update persists beyond signing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so every parameter is already documented, which sets the baseline at 3. The description reinforces a few constraints (email, mobile, or both; name optional with the record name as fallback; i_am_this_clinician gating) but adds little that the schema does not already say.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a concrete operation: designate who signs one clinician's written applications, keyed by account_id, access_token, and npi. That is a specific verb+resource an agent can act on. It does not name a sibling alternative (e.g. payer_follow_up_signers, which only lists eligible clinicians), so it falls short of full sibling differentiation.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage is only implied: the tool is for supplying the signer's contact so a waiting application can be signed, and resend_link true re-sends. There is no explicit statement of when to call this versus payer_follow_up_signers or payer_follow_up_request, and no exclusion cases. The schema descriptions carry the routing hints instead.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.